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Cases first notified to a Registry and successfully followed back have an apparently worse prognosis than cases registered in life. A
simple approach can be used to assess whether this is due to selection bias, incomplete follow-back or intrinsically higher mortality.
For the colorectal, breast and stomach cancers studied and for comparable registries, the main explanations are likely to be selection
bias and higher mortality.
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Death Certificate Only registrations (DCOs), well known to cancer
registries, are registrations for which the death certificate is the
only evidence for a diagnosis of cancer. Such cases are a subset of
those registrations that are only initiated after death, and may be
termed Death Certificate Initiated registrations (DCIs), or Death
Certificate Notifications (DCNs). Most DCIs can, after follow-back,
be linked successfully to hospital records to obtain the original
date of diagnosis and it is useful to introduce the term traced DCIs
for these. Death certificate only registrations therefore arise either
when attempts to follow-back DCIs fail (because a hospital record
cannot be found at all), or when DCIs are successfully linked to
hospital records but these records give an alternative diagnosis or
contain no supporting evidence for cancer. It has therefore been
recommended that the latter category should be specially flagged
or even excluded from cancer incidence estimates (Powell, 1991);
this is not universal practice, however.
Although the percentage of DCO registrations is an important
measure of the quality of registry data (Parkin et al, 1994), in many
registries the reported percentage of DCOs includes both DCOs
and DCIs for which no follow-back attempts have been made. It
is important to be aware, therefore, that the reported percentage of
DCOs may overestimate the true percentage of DCOs as defined
above (% true DCO), depending on how much resource is devoted
to follow-back.
Most cancer registrations, however, are made from hospital
records (including pathology and other hospital-based sources
such as clinical databases) while the patient is still alive. There
seems to be no standard term for this broad category and in this
paper they are referred to as Registered In Life (RIL) registrations.
It is well known in registries that traced DCI cases have worse
survival than RIL cases (see Figure 1), and for this there are three
possible explanations:
(a) selection bias, because DCIs are far from being a random
sample of cases;
(b) incomplete follow-back, because the earliest recorded date is
derived from a more recent hospital attendance than the actual
diagnosis date. This may occur, for example, if the original
medical notes are missing, and the diagnosis date is taken
from attendance for treatment of recurrent disease;
(c) intrinsically greater mortality, due to greater age, co-
morbidity, or more advanced or more aggressive disease.
This study aimed to quantify these possibilities by taking RIL
cases from a registry database and modifying the records to see
how big the changes would have to be to produce a survival curve
resembling that of actual traced DCIs.
METHODS
All colorectal cancer registrations for 2000 in the Trent Region
were extracted from the Registry database in January 2005 and
classed as DCO, Traced DCI or RIL.
The survival of traced DCI cases was compared with that of RIL
cases by Kaplan–Meier survival plots (Figure 1). It was assumed
that the separate hazard ratios of selection bias, incomplete follow-
back and mortality would be multiplicative, their product being
the hazard ratio observed for traced DCI cases relative to RIL
cases, denoted by RDCI, which is the value to be accounted for in
possibilities (a) to (c). This model supposes that if St is the survival
of cases registered in life at time t after diagnosis, then the survival
of DCI cases is given by S
RDCI
t with RDCI being given by:
RDCI ¼ Rselection Rfollow back Rmortality
where RDCI is observed directly, Rselection is estimated from dead
RIL cases, Rfollow-back is estimated using ‘reasonable’ assumptions
and Rmortality is what remains.
To answer possibility (a) the RIL cases were duplicated and then
split into two equal groups. One group was labelled as ‘pseudo-
DCIs’ and for this group only cases that had died were retained
(because DCIs are, by definition dead). Comparison of the survival
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y(as before) of these pseudo-DCIs with the remaining RIL cases
indicated the contribution of selection bias alone through hazard
ratio Rselection. The reduced hazard ratio due only to incomplete
follow-back and mortality, RDCI_reduced¼Rfollow-back Rmortality,
was estimated as: RDCI/Rselection.
To assess possibility (b) – the contribution of incomplete follow-
back – it was assumed that for any individual traced DCI case, a
maximum fraction of the true survival time t will be missed (see
Figure 2). For simplicity, assuming that the missing increment
has a uniform distribution on the interval [0, yt] then the average
amount of time missed is 1
2yt. As the survival time actually
observed due to follow-back, ttraced must then be (1 y)t, the
missing increment will have a uniform distribution on the range
(0, y.ttraced/(1–y)) by substituting t¼ttraced/(1 y); the average
amount of time missed will be half of this, that is 1
2yttraced=ð1   yÞ.
The survival time based on follow-back can then be corrected for
an assumed fraction missing by adding this increment. An
alternative approach was also tried, in which the missed increment
has a negative exponential distribution with the same mean, which
might be more realistic as it does not constrain the maximum
amount of time that could be missed. The choice of model does not
affect the value for Rselection or of course the observed value RDCI.
As correcting for incomplete follow-back increases the survival
time for pseudo-DCIs, the effect is to reduce the hazard ratio
relative to RIL cases, so the corrected hazard ratio then observed
Rcorrected is actually (1/Rfollow-back) Rselection. We already know
Rselection so we can estimate Rfollow-back as Rselection/Rcorrected. Note
that because these are pseudo-DCIs there is no effect of
intrinsically higher mortality.
The hazard ratio Rfollow-back was then estimated for different values
of y,a n dt h ec r i t i c a lv a l u ea tw h i c hRfollow-back equalled the value
unaccounted for by selection bias was found by cubic interpolation.
Finally to address possibility (c), for each value of y the hazard
ratio among real traced DCIs due to intrinsically higher mortality
was estimated by Rmortality¼RDCI /(Rselection Rtraceback).
Similar analyses were performed for stomach and breast cancers
representing tumours with worse and better survival respectively
(these had not been subject to extensive follow-back activity).
Calculations were performed in Stata version 9.
RESULTS
Of 2896 colorectal cases, 16.9% were DCIs, 4.4% were DCOs and
the remainder were registered in life. A cumulative hazards plot
(Collett, 1994) showed that the proportional hazards assumption
was reasonable for comparing traced DCIs and RIL cases at least
for 5 years survival; the hazard ratio of traced DCIs to ‘known’
cases was 12.32 (Figure 1).
Table 1 displays the results for different assumed proportions
missing. It is clear that incomplete follow-back (on top of selection
bias) cannot account for the poorer survival of DCIs unless the
maximum proportion missing is more than 80% (40% missed on
average). For ‘plausible’ maximum proportions lost in the region
of 10–20% Rmortality was at least twice that of Rfollow-back, although
Kaplan-Meier survival estimates, by regtype
Analysis time (years)
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Figure 1 Survival of Registered in Life and traced DCI cases (colorectal
cancer).
True time of diagnosis
Apparent time of diagnosis Time of death
True survival t
(Arbitrary time units)
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Figure 2 Imputing missed survival.
Table 1 Breakdown of hazard ratio components assuming multiplicative hazards (colorectal cancer)
Hazard ratio to be accounted for: RDCI 12.32
Due to selection bias Rselection 3.80
Unaccounted for by selection bias 3.25
Uniform distribution Exponential distribution
Max prop
missed
Average prop
missed (%) Rtraceback Rmortality
Average
prop
missed (%) Rtraceback Rmortality
0.10 5 1.06 3.07 5 1.06 3.05
0.15 7.5 1.10 2.94 7.5 1.11 2.92
0.20 10 1.15 2.82 10 1.15 2.82
0.30 15 1.27 2.55 15 1.25 2.59
0.40 20 1.42 2.28 20 1.38 2.35
0.50 25 1.60 2.03 25 1.54 2.10
0.60 30 1.86 1.75 30 1.86 1.82
0.70 35 2.24 1.45 35 2.24 1.54
0.80 40 2.96 1.10 40 2.65 1.23
0.82* 41* 3.25 1.00 41* 3.25 1.00
*Value accounting for all excess apart from selection bias.
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ystill smaller than Rselection. Table 1 also shows that the results of the
a l t e r n a t i v ee x p o n e n t i a lm o d e lf o rt h em i s s e ds u r v i v a lt i m ew e r es i m i l a r .
The supplementary analyses for stomach and breast cancer are
shown in Table 2, using only results from the uniform distribution
model. The general conclusions are similar, but selection bias was
relatively less important for stomach cancer while for breast cancer
the opposite applied. This may be because selection on the fact
of death cannot make much difference to apparent survival for
cancers with a very poor prognosis.
DISCUSSION
The worse survival of DCI cases relative to RIL cases was partly,
but by no means entirely, reproduced by selection bias. To obtain
a large contribution due to incomplete follow-back required an
implausibly high proportion of missed survival time, and with
more plausible values the main factors were selection bias and
intrinsically higher mortality. This result may be helpful when, for
example, building simulation models of cancer registration in
order to decide whether the effect of incomplete trace-back may
reasonably be ignored.
Limitations of this study are, firstly, the extent to which a
proportional hazards model applies for each component. This
proportionality assumption does not have to be true, as long as it
is a reasonable approximation – but of course, as we are dealing
with unknowns the approach also has the advantage of simplicity.
In any case the results should be viewed as indicative rather than
exact. Secondly, the way the missed survival time has been
estimated automatically may give a greater increment to cases with
longer traced survival, although formulating the missed time as a
fraction of the true value seemed a natural approach. An attempt to
mimic missed increments inversely related to the followed-back
survival resulted in markedly crossed survival curves with a
strange sigmoid survival for pseudo-DCIs, so this seems unlikely
to be realistic. Thirdly, the results strictly apply only to colorectal,
breast and stomach cancer, and to registries with similar practices
to Trent Cancer Registry; nevertheless the approach described
could easily be adopted generally.
The key lesson of this paper is that as incomplete follow-back of
survival is unlikely to miss much survival time, registry resources
devoted to follow-back should be directed towards linking a higher
proportion of DCI patients with hospital records, rather than
scrupulously checking the completeness of each patient’s history.
There are also opportunities for further research, for example:
validation by intensive efforts to obtain actual diagnosis dates for
DCIs; similar studies of other tumour sites or in registries with
different working practices; and the use of different models for the
missed survival.
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Table 2 Breakdown of hazard ratio components assuming multiplicative
hazards (stomach and breast cancers)
Uniform distribution
‘Max’ prop missed
Average prop
missed (%) Rtraceback Rmortality
(a) Stomach cancer
Hazard ratio to be accounted for RDCI 5.39
Due to selection bias Rselection 1.64
Unaccounted for by selection bias 3.28
0.10 5 1.04 3.15
0.15 7.5 1.07 3.08
0.20 10 1.09 3.01
0.30 15 1.16 2.82
0.40 20 1.26 2.60
0.50 25 1.39 2.36
0.60 30 1.60 2.09
0.70 35 1.85 1.77
0.80 40 2.35 1.40
0.88* 44* 3.28 1.00
(b) Breast cancer
Hazard ratio to be accounted for RDCI 21.70
Due to selection bias Rselection 10.12
Unaccounted for by selection bias 2.14
0.10 5 1.09 1.96
0.15 7.5 1.15 1.86
0.20 10 1.24 1.74
0.30 15 1.48 1.45
0.40 20 1.74 1.23
0.50* 25* 2.14 1.00
*Value accounting for all excess apart from selection bias.
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